128 related articles for article (PubMed ID: 35773089)
1. IgG N-glycome changes during the course of severe COVID-19: An observational study.
Petrović T; Vijay A; Vučković F; Trbojević-Akmačić I; Ollivere BJ; Marjanović D; Bego T; Prnjavorac B; Đerek L; Markotić A; Lukšić I; Jurin I; Valdes AM; Hadžibegović I; Lauc G
EBioMedicine; 2022 Jul; 81():104101. PubMed ID: 35773089
[TBL] [Abstract][Full Text] [Related]
2. Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome.
Vučković F; Krištić J; Gudelj I; Teruel M; Keser T; Pezer M; Pučić-Baković M; Štambuk J; Trbojević-Akmačić I; Barrios C; Pavić T; Menni C; Wang Y; Zhou Y; Cui L; Song H; Zeng Q; Guo X; Pons-Estel BA; McKeigue P; Leslie Patrick A; Gornik O; Spector TD; Harjaček M; Alarcon-Riquelme M; Molokhia M; Wang W; Lauc G
Arthritis Rheumatol; 2015 Nov; 67(11):2978-89. PubMed ID: 26200652
[TBL] [Abstract][Full Text] [Related]
3. Composition of the immunoglobulin G glycome associates with the severity of COVID-19.
Petrović T; Alves I; Bugada D; Pascual J; Vučković F; Skelin A; Gaifem J; Villar-Garcia J; Vicente MM; Fernandes Â; Dias AM; Kurolt IC; Markotić A; Primorac D; Soares A; Malheiro L; Trbojević-Akmačić I; Abreu M; Sarmento E Castro R; Bettinelli S; Callegaro A; Arosio M; Sangiorgio L; Lorini LF; Castells X; Horcajada JP; Pinho SS; Allegri M; Barrios C; Lauc G
Glycobiology; 2021 May; 31(4):372-377. PubMed ID: 33174592
[TBL] [Abstract][Full Text] [Related]
4. Profile of Immunoglobulin G
Hou H; Yang H; Liu P; Huang C; Wang M; Li Y; Zhu M; Wang J; Xu Y; Wang Y; Ma Q; Li D; Liao P; Wang W
Front Immunol; 2021; 12():748566. PubMed ID: 34630427
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19.
Pongracz T; Nouta J; Wang W; van Meijgaarden KE; Linty F; Vidarsson G; Joosten SA; Ottenhoff THM; Hokke CH; de Vries JJC; Arbous SM; Roukens AHE; Wuhrer M; ;
EBioMedicine; 2022 Apr; 78():103957. PubMed ID: 35334306
[TBL] [Abstract][Full Text] [Related]
6. Altered IgG glycosylation at COVID-19 diagnosis predicts disease severity.
Vicente MM; Alves I; Gaifem J; Rodrigues CS; Fernandes Â; Dias AM; Štambuk J; Petrović T; Oliveira P; Ferreira-da-Silva F; Soares A; Seixas N; Teixeira T; Malheiro L; Abreu MM; Lauc G; Sarmento E Castro R; Pinho SS
Eur J Immunol; 2022 Jun; 52(6):946-957. PubMed ID: 35307819
[TBL] [Abstract][Full Text] [Related]
7. The IgG glycome of SARS-CoV-2 infected individuals reflects disease course and severity.
Siekman SL; Pongracz T; Wang W; Nouta J; Kremsner PG; da Silva-Neto PV; Esen M; Kreidenweiss A; Held J; Trapé ÁA; Fendel R; de Miranda Santos IKF; Wuhrer M;
Front Immunol; 2022; 13():993354. PubMed ID: 36389824
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome.
Trbojević Akmačić I; Ventham NT; Theodoratou E; Vučković F; Kennedy NA; Krištić J; Nimmo ER; Kalla R; Drummond H; Štambuk J; Dunlop MG; Novokmet M; Aulchenko Y; Gornik O; Campbell H; Pučić Baković M; Satsangi J; Lauc G;
Inflamm Bowel Dis; 2015 Jun; 21(6):1237-47. PubMed ID: 25895110
[TBL] [Abstract][Full Text] [Related]
9. Differences in Immunoglobulin G Glycosylation Between Influenza and COVID-19 Patients.
Kljaković-Gašpić Batinjan M; Petrović T; Vučković F; Hadžibegović I; Radovani B; Jurin I; Đerek L; Huljev E; Markotić A; Lukšić I; Trbojević-Akmačić I; Lauc G; Gudelj I; Čivljak R
Engineering (Beijing); 2022 Sep; ():. PubMed ID: 36093331
[TBL] [Abstract][Full Text] [Related]
10. High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations.
Pucić M; Knezević A; Vidic J; Adamczyk B; Novokmet M; Polasek O; Gornik O; Supraha-Goreta S; Wormald MR; Redzić I; Campbell H; Wright A; Hastie ND; Wilson JF; Rudan I; Wuhrer M; Rudd PM; Josić D; Lauc G
Mol Cell Proteomics; 2011 Oct; 10(10):M111.010090. PubMed ID: 21653738
[TBL] [Abstract][Full Text] [Related]
11. Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies.
Cheetham NJ; Kibble M; Wong A; Silverwood RJ; Knuppel A; Williams DM; Hamilton OKL; Lee PH; Bridger Staatz C; Di Gessa G; Zhu J; Katikireddi SV; Ploubidis GB; Thompson EJ; Bowyer RCE; Zhang X; Abbasian G; Garcia MP; Hart D; Seow J; Graham C; Kouphou N; Acors S; Malim MH; Mitchell RE; Northstone K; Major-Smith D; Matthews S; Breeze T; Crawford M; Molloy L; Kwong ASF; Doores K; Chaturvedi N; Duncan EL; Timpson NJ; Steves CJ
Elife; 2023 Jan; 12():. PubMed ID: 36692910
[TBL] [Abstract][Full Text] [Related]
12. Ischemic stroke is associated with the pro-inflammatory potential of N-glycosylated immunoglobulin G.
Liu D; Zhao Z; Wang A; Ge S; Wang H; Zhang X; Sun Q; Cao W; Sun M; Wu L; Song M; Zhou Y; Wang W; Wang Y
J Neuroinflammation; 2018 Apr; 15(1):123. PubMed ID: 29699572
[TBL] [Abstract][Full Text] [Related]
13. Bulk IgG glycosylation predicts COVID-19 severity and vaccine antibody response.
Ash MK; Bhimalli PP; Cho BK; Mattamana BB; Gambut S; Tarhoni I; Fhied CL; Reyes AF; Welninski SJ; Arivalagan J; Negrão F; Goel R; Beck TL; Hope TJ; Sha BE; Goo YA; Al-Harthi L; Mamede JI; Borgia JA; Kelleher NL; Schneider JR
Cell Rep; 2022 Dec; 41(11):111799. PubMed ID: 36493786
[TBL] [Abstract][Full Text] [Related]
14. Changes of IgG
Trzos S; Link-Lenczowski P; Sokołowski G; Pocheć E
Front Immunol; 2022; 13():841710. PubMed ID: 35370997
[TBL] [Abstract][Full Text] [Related]
15. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation of the
Klasić M; Markulin D; Vojta A; Samaržija I; Biruš I; Dobrinić P; Ventham NT; Trbojević-Akmačić I; Šimurina M; Štambuk J; Razdorov G; Kennedy NA; Satsangi J; Dias AM; Pinho S; Annese V; Latiano A; D'Inca R; ; Lauc G; Zoldoš V
Clin Epigenetics; 2018; 10():75. PubMed ID: 29991969
[TBL] [Abstract][Full Text] [Related]
17. IgG N-glycans.
Liu S; Liu X
Adv Clin Chem; 2021; 105():1-47. PubMed ID: 34809825
[TBL] [Abstract][Full Text] [Related]
18. mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine.
Buhre JS; Pongracz T; Künsting I; Lixenfeld AS; Wang W; Nouta J; Lehrian S; Schmelter F; Lunding HB; Dühring L; Kern C; Petry J; Martin EL; Föh B; Steinhaus M; von Kopylow V; Sina C; Graf T; Rahmöller J; Wuhrer M; Ehlers M
Front Immunol; 2022; 13():1020844. PubMed ID: 36713457
[TBL] [Abstract][Full Text] [Related]
19. Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases.
Deakin CT; Cornish GH; Ng KW; Faulkner N; Bolland W; Hope J; Rosa A; Harvey R; Hussain S; Earl C; Jebson BR; Wilkinson MGLL; Marshall LR; O'Brien K; Rosser EC; Radziszewska A; Peckham H; Patel H; Heaney J; Rickman H; Paraskevopoulou S; Houlihan CF; Spyer MJ; Gamblin SJ; McCauley J; Nastouli E; Levin M; Cherepanov P; Ciurtin C; Wedderburn LR; Kassiotis G
Med; 2021 Sep; 2(9):1093-1109.e6. PubMed ID: 34414384
[TBL] [Abstract][Full Text] [Related]
20. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.
To KK; Tsang OT; Leung WS; Tam AR; Wu TC; Lung DC; Yip CC; Cai JP; Chan JM; Chik TS; Lau DP; Choi CY; Chen LL; Chan WM; Chan KH; Ip JD; Ng AC; Poon RW; Luo CT; Cheng VC; Chan JF; Hung IF; Chen Z; Chen H; Yuen KY
Lancet Infect Dis; 2020 May; 20(5):565-574. PubMed ID: 32213337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
